Tag: SWVI

SWVI, ESWB & Extended Watchlist

Swingplane Ventures Inc. SWVI

We’ve been tracking SWVI since January 23rd, when the stock was trading at just a fraction of what it is today. We saw it run from a low of .1843 that day, and continue to trend upward in the weeks that followed, reaching a high of .84 yesterday. That impressive range represents a potential profit of 356% for ourselves and our readers, so congratulations to anyone who was able to take advantage of that incredible opportunity.

___

Esio Water and Beverage Development Corp. ESWB

ESWB is another stock we’ve had our eye on for the past few weeks, but are mentioning it for the first time today. We like ESWB for the interesting product they offer.

The ESIO Beverage System is one of the more cutting-edge offerings that we’ve found in the OTC Food and Beverage Sector in quite awhile. Through the use of patented delivery system called Esio-Paks, and mixing technology in the system itself, combined with always on, always ready supplies of hot and cold water, the Esio system allows users the ability to enjoy a wide range of hot or cold beverages on demand. The unit takes up about as much counter space as the average coffee maker, and has the convenience and versatility of a Kuerig machine, but with the added ability to provide cold beverages as well.

We definitely want to keep an eye on this newly-trading stock moving forward, because a machine like the Esio Beverage System could really take off quickly. Especially when considering the fact that it is already available at Walmart stores. Expect to see ESWB remain on our watchlist for months to come.

___

Extended Watchlist:
SNDY, CNCT, CERP, 

BMSN, KERX & Extended Watchlist

Bio-Matrix Scientific Group, Inc. BMSN

BMSN has been a main point of focus for us this year. We first began paying close attention to BMSN towards the end of 2012 when it was trading as low as .0003. Yesterday, the stock had another rockstar performance, reaching new highs and cracking through another major resistance point at .0035 (200DMA).

After the initial surge we saw from .0003-.0024, we wanted to see support hold off of .001. Now that we have hit new highs, we are raising the bar and looking for new support to hold  at .0035, or below that, the 20DMA of .0021. If we can see these areas hold as support, we are going to remain bullish on BMSN.

Over the span of our coverage on BMSN, we have been afforded the opportunity at an accumulation of up to 1400% in possible gains from .0003 to yesterday’s high of .0045

Most Recent News:

SAN DIEGO, CA, Jan 24, 2013 (MARKETWIRE via COMTEX) — Regen BioPharma, a wholly owned subsidiary of Bio-Matrix Scientific Group Inc. (PINKSHEETS: BMSN), announced today publication in a peer reviewed medical journal the scientific basis for its HemaXellerate(TM) bone marrow failure product. The manuscript is available at http://www.translational-medicine.com/content/pdf/1479-5876-10-231.pdf. The publication is an overview of the Investigational New Drug (IND) application that the company plans to file for initiating clinical trials.

__

Keryx Biopharmaceuticals, Inc. KERX

KERX earned us a spot in the Penny Stock Rumble on Tuesday, racking up another solid day of gains, and hitting a high of 8.79. That brings our total possible profits to a very respectable 154%

We are going to be monitoring the activity on KERX following yesterday’s announcement regarding the comnpany’s planned $55M public offering.

Yesterday’s News:

NEW YORK, Jan. 29, 2013 /PRNewswire via COMTEX/ — Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) today announced that it has commenced a $55 million underwritten public offering of shares of its common stock. In connection with this offering, Keryx expects to grant to the underwriters a 30-day option to purchase additional shares of common stock, equal to up to 15% of the number of shares of common stock sold in the offering. J.P. Morgan is acting as the sole book-running manager in the offering.

__

Extended Watchlist:
SCXN, ITNS, MYRY, SWVI, ONCI, ENTB

CERP, SWVI & Extended Watchlist

Cereplast, Inc. CERP

After appearing on yesterday’s extended watchlist, CERP gapped up slightly at the open .0288 from the prior close of .0248. We saw a slight pullback to fill part of that gap, with the stock dipping as low as .025 first thing yesterday morning, after which it proceeded to push to a high of .0449 by early afternoon. The differential from low to high produced an opportunity for us to rake in up to 80% in profits on the day.

This stock is coming off of a dead-cat bottom, so we’d like to see it get above the 50DMA of .0552 for us to remain bullish. As you can see on the chart, indicators are starting to look strong, with the RSI coming off of being oversold and getting ready to pass through the 50-line. The PPO and the Slow STO just crossed over, and momentum is looking strong, with volume picking up over the past few days.

____

Swingplane Ventures Inc. SWVI

SWVI is another stock off of our extended watchlist from yesterday- this one gapped up to .19 after a previous close at .17. We saw a slight pullback to .1843, before the stock surged as high as .295 (closed @ .2899). In all, total intraday gains of 60% were possible, on huge volume to the tune of 88M shares.

We want to be cautious here, even while there may be gains still left to be made. We’ve seen a few large promo outfits touting this stock recently, so we just need to keep aware, and scan for the impending collapse that most often follows a big promotional push. The tail-end of those pullbacks generally produce bounceplay opportunities, of which we fully intend to take advantage. It will be all about timing when this comes to pass. We’ve been spot-on in timing the actions of SWVI so far, so join us in keeping this play on your watchlist as this round of promotions runs its course.

____

Side Note:

Of the remaining three stocks to appear on yesterday’s extended watchlist, two posted gains on the day: Pharma-plays PATH and KERX. It was actually the third day running that we mentioned PATH, which has made gains of 21% over just a few short days; quite a feat for a big board stock. This was on the strength of a news release outlining the company’s new treatment for acute migraines.

____

Extended Watchlist:
EMWW, FARE, NEWL, XRX, BIOD, CARV, RVLT